William Blair & Company
ASMB icon

William Blair & Company’s Assembly Biosciences ASMB Stock Holding History

William Blair & Company’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,333
Closed -$62K – 1881
2021
Q2 		$62K Sell
1,333
-42
-3% -$2.08K ﹤0.01% 1667
2021
Q1 		$76K Buy
+1,375
New +$91.1K ﹤0.01% 1625
2020
Q4 		– Sell
-1,000
Closed -$197K – 1819
2020
Q3 		$197K Sell
1,000
-71
-7% -$17.9K ﹤0.01% 1308
2020
Q2 		$300K Hold
1,071
– – ﹤0.01% 1091
2020
Q1 		$191K Sell
1,071
-2,953
-73% -$633K ﹤0.01% 1176
2019
Q4 		$988K Buy
4,024
+3,191
+383% +$588K 0.01% 782
2019
Q3 		$98K Sell
833
-152
-15% -$23K ﹤0.01% 1384
2019
Q2 		$160K Buy
985
+83
+9% +$15.8K ﹤0.01% 1355
2019
Q1 		$213K Buy
902
+140
+18% +$35.4K ﹤0.01% 1279
2018
Q4 		$207K Sell
762
-45
-6% -$13K ﹤0.01% 1220
2018
Q3 		$360K Sell
807
-250
-24% -$117K ﹤0.01% 1060
2018
Q2 		$497K Sell
1,057
-19
-2% -$10K ﹤0.01% 953
2018
Q1 		$635K Buy
1,076
+501
+87% +$311K ﹤0.01% 844
2017
Q4 		$312K Buy
+575
New +$260K ﹤0.01% 1117
2017
Q2 		– Sell
-3,404
Closed -$852K – 1624
2017
Q1 		$852K Hold
3,404
– – 0.01% 752
2016
Q4 		$496K Hold
3,404
– – ﹤0.01% 840
2016
Q3 		$295K Hold
3,404
– – ﹤0.01% 1018
2016
Q2 		$227K Hold
3,404
– – ﹤0.01% 1083
2016
Q1 		$205K Sell
3,404
-417
-11% -$27.9K ﹤0.01% 1065
2015
Q4 		$344K Buy
3,821
+2,238
+141% +$244K ﹤0.01% 915
2015
Q3 		$181K Buy
1,583
+750
+90% +$132K ﹤0.01% 1293
2015
Q2 		$192K Buy
+833
New +$161K ﹤0.01% 2067
2013
Q4 		– Sell
-208
Closed -$36K – 2002
2013
Q3 		$36K Buy
+208
New +$31.9K ﹤0.01% 1993

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

William Blair & Company's ASMB Position: Q3 2021 in Review

William Blair & Company sold out of Assembly Biosciences (ASMB) in Q3 2021, closing a stake of 1,333 shares — an estimated $62K sold.

William Blair & Company first reported a position in ASMB in Q3 2013 and held it in 23 quarters. The position peaked at $988K in Q4 2019. 65 funds tracked by Wall St. Rank hold ASMB as of Q3 2021.

  • William Blair & Company reported no remaining Assembly Biosciences position as of Q3 2021 after selling out during the quarter.
  • William Blair & Company sold 1,333 Assembly Biosciences shares in Q3 2021, an estimated $62K.
  • William Blair & Company first reported a position in Assembly Biosciences in Q3 2013 and held it in 23 quarters.
  • William Blair & Company's Assembly Biosciences position peaked at $988K in Q4 2019.
  • 65 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2021.

Based on William Blair & Company's 13F filing for Q3 2021, filed 12 Nov 2021.